More Stories

Informist, Thursday, Jul. 3, 2025

 

--HC bars Patanjali Ayurved from airing disparaging advt against Dabur India 

--CONTEXT: Dabur India alleged disparagement by Patanjali Ayurved on chawanprash 

 

NEW DELHI – In an interim injunction order passed on Thursday, the Delhi High Court restrained Patanjali Ayurved Ltd. from airing television commercials which were disparaging Dabur India Ltd.'s Chyawanprash products. A detailed order is awaited.

 

Dabur India had said the advertisements incorrectly claimed Patanjali Ayurved's product was made using more than 51 herbs. Patanjali Ayurved is using only 47 herbs, said Dabur India, adding that it was "misinformation to the public at large". The petitioner said that Patanjali Ayurved has specifically referred to Dabur's product made with using 40 herbs as ordinary. "They refer to us as ordinary. They make a market leader ordinary," said Dabur India, adding that it holds a dominant 61.6% market share in the Chyawanprash segment. Further, Dabur India said that Patanjali was using mercury in its Chyawanprash product, which was not fit for consumption by children.

 

Earlier, Dabur India had highlighted Patanjali Ayurved's commercial which said that those who lack knowledge of Ayurved and Vedic traditions cannot produce the "original" Chyawanprash. Dabur India had said that the statement implied that only Patanjali Ayurved's product was authentic, while other brands were inferior or fake.

 

Patanjali Ayurved, the parent company of Patanjali Foods Ltd., is a habitual offender in misleading the public, said Dabur India's counsel. Earlier, the high court had asked Patanjali Ayurved's co-founder Baba Ramdev to take down his statements claiming that allopathy was responsible for the death of millions of people during COVID-19 and that Patanjali's Coronil was a cure for the virus, said Dabur's counsel.

 

Even the Supreme Court had initially started a contempt case against Patanjali Ayurved, Baba Ramdev, and Managing Director Acharya Balkrishna for publishing misleading advertisements for its ayurvedic products and violating the top court's order, said Dabur's counsel. Closing the contempt proceedings in August, the apex court had 'strictly' warned Patanjali, Ramdev, and Balkrishna that they would not do anything in violation of its orders as had happened earlier in the case. 

 

At 1110 IST, the shares of Patanjali Foods Ltd. were up 0.1% at INR 1,640.30, while those of Dabur India were up 0.8% at INR 491.65 on the National Stock Exchange. End

 

IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT

 

Reported by Surya Tripathi

Edited by Deepshikha Bhardwaj

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd by NSE Data & Analytics Ltd, a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt Ltd.

 

Informist Media Tel +91 (11) 4220-1000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2025. All rights reserved.